Literature DB >> 30245128

Iron attenuates erythropoietin production by decreasing hypoxia-inducible transcription factor 2α concentrations in renal interstitial fibroblasts.

Norio Suzuki1, Yukari Matsuo-Tezuka2, Yusuke Sasaki2, Koji Sato3, Kenichiro Miyauchi3, Koichiro Kato3, Sakae Saito4, Yasushi Shimonaka2, Michinori Hirata2, Masayuki Yamamoto4.   

Abstract

Iron is an essential mineral for oxygen delivery and for a variety of enzymatic activities, but excessive iron results in oxidative cytotoxicity. Because iron is primarily used in red blood cells, defective erythropoiesis caused by loss of the erythroid growth factor erythropoietin (Epo) elevates iron storage levels in serum and tissues. Here, we investigated the effects of iron in a mouse model of Epo-deficiency anemia, in which serum iron concentration was significantly elevated. We found that intraperitoneal injection of iron-dextran caused severe iron deposition in renal interstitial fibroblasts, the site of Epo production. Iron overload induced by either intraperitoneal injection or feeding decreased activity of endogenous Epo gene expression by reducing levels of hypoxia-inducible transcription factor 2α (HIF2α), the major transcriptional activator of the Epo gene. Administration of an iron-deficient diet to the anemic mice reduced serum iron to normal concentration and enhanced the ability of renal Epo production. These results demonstrate that iron overload due to Epo deficiency attenuates endogenous Epo gene expression in the kidneys. Thus, iron suppresses Epo production by reducing HIF2α concentration in renal interstitial fibroblasts.
Copyright © 2018 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HIF2α; erythropoietin; iron; mouse model; renal anemia; renal interstitium

Mesh:

Substances:

Year:  2018        PMID: 30245128     DOI: 10.1016/j.kint.2018.06.028

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  13 in total

1.  Distinct Regulations of HO-1 Gene Expression for Stress Response and Substrate Induction.

Authors:  Anqi Zhang; Takafumi Suzuki; Saki Adachi; Eriko Naganuma; Norio Suzuki; Tomonori Hosoya; Ken Itoh; Michael B Sporn; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2021-08-16       Impact factor: 4.272

Review 2.  New insights into the links between hypoxia and iron homeostasis.

Authors:  Cyril Renassia; Carole Peyssonnaux
Journal:  Curr Opin Hematol       Date:  2019-05       Impact factor: 3.284

3.  TAM-ing the CIA-Tumor-Associated Macrophages and Their Potential Role in Unintended Side Effects of Therapeutics for Cancer-Induced Anemia.

Authors:  Stefan Weiler; Manfred Nairz
Journal:  Front Oncol       Date:  2021-03-25       Impact factor: 6.244

4.  Changes in Hepcidin Levels in an Animal Model of Anemia of Chronic Inflammation: Mechanistic Insights Related to Iron Supplementation and Hepcidin Regulation.

Authors:  Hye-Bin Kim; Ji Hae Jun; Jae-Kwang Shim; Ju Eun Oh; Cheolhun Lee; Young-Lan Kwak
Journal:  Oxid Med Cell Longev       Date:  2021-11-27       Impact factor: 6.543

5.  Effects of Roxadustat on Erythropoietin Production in the Rat Body.

Authors:  Yukiko Yasuoka; Yuichiro Izumi; Takashi Fukuyama; Haruki Omiya; Truyen D Pham; Hideki Inoue; Tomomi Oshima; Taiga Yamazaki; Takayuki Uematsu; Noritada Kobayashi; Yoshitaka Shimada; Yasushi Nagaba; Tetsuro Yamashita; Masashi Mukoyama; Yuichi Sato; Susan M Wall; Jeff M Sands; Noriko Takahashi; Katsumasa Kawahara; Hiroshi Nonoguchi
Journal:  Molecules       Date:  2022-02-08       Impact factor: 4.411

6.  An immortalized cell line derived from renal erythropoietin-producing (REP) cells demonstrates their potential to transform into myofibroblasts.

Authors:  Koji Sato; Ikuo Hirano; Hiroki Sekine; Kenichiro Miyauchi; Taku Nakai; Koichiro Kato; Sadayoshi Ito; Masayuki Yamamoto; Norio Suzuki
Journal:  Sci Rep       Date:  2019-08-02       Impact factor: 4.379

Review 7.  Alteration of the DNA Methylation Signature of Renal Erythropoietin-Producing Cells Governs the Sensitivity to Drugs Targeting the Hypoxia-Response Pathway in Kidney Disease Progression.

Authors:  Koji Sato; Naonori Kumagai; Norio Suzuki
Journal:  Front Genet       Date:  2019-11-13       Impact factor: 4.599

Review 8.  Hypoxia Pathway Proteins are Master Regulators of Erythropoiesis.

Authors:  Deepika Watts; Diana Gaete; Diego Rodriguez; David Hoogewijs; Martina Rauner; Sundary Sormendi; Ben Wielockx
Journal:  Int J Mol Sci       Date:  2020-10-30       Impact factor: 5.923

9.  Molecular characterization of the human kidney interstitium in health and disease.

Authors:  Daria Barwinska; Tarek M El-Achkar; Ricardo Melo Ferreira; Farooq Syed; Ying-Hua Cheng; Seth Winfree; Michael J Ferkowicz; Takashi Hato; Kimberly S Collins; Kenneth W Dunn; Katherine J Kelly; Timothy A Sutton; Brad H Rovin; Samir V Parikh; Carrie L Phillips; Pierre C Dagher; Michael T Eadon
Journal:  Sci Adv       Date:  2021-02-10       Impact factor: 14.136

10.  Abnormal whole-body energy metabolism in iron-deficient humans despite preserved skeletal muscle oxidative phosphorylation.

Authors:  Matthew C Frise; David A Holdsworth; Andrew W Johnson; Yu Jin Chung; M Kate Curtis; Pete J Cox; Kieran Clarke; Damian J Tyler; David J Roberts; Peter J Ratcliffe; Keith L Dorrington; Peter A Robbins
Journal:  Sci Rep       Date:  2022-01-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.